Cantor Fitzgerald Analyst Reiterates Overweight Rating on 89bio with 29 Price Target
On March 4, 2024, analyst Kristen Kluska from Cantor Fitzgerald reiterated an optimistic "Overweight" rating on 89bio (NASDAQ: ETNB) with ...
Tag: ETNB
Analyst Downgrades 89bio Rating and Sets 15 Price Target
On January 12, 2024, Brian Abrahams, an analyst from RBC Capital, made a significant update regarding 89bio (NASDAQ: ETNB). Abrahams ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Institutional Investors Rally Behind GXO Logistics
